<img alt="" src="https://secure.lote1otto.com/219869.png" style="display:none;">


Flexible approaches to trial design – from exploratory designs that more effectively target the maximum tolerated dose, to population enrichment methods that support precision medicine, have the potential to improve efficiency and reduce risk.

Download our ebook and discover how our strategic consultancy group
helps clients create and apply innovative trial designs within
exploratory and confirmatory oncology development.

Designs include:

Model-Based Bayesian Design for Phase 1/2a Trial

Hybrid Model/ Rule-based Design for Phase 1 Combination Trial

Phase 2 Hematological Oncology Trial Comparing Treatment Overall Response Rate to Historical Control

Innovative Phase 3 Adaptive Enrichment Design Reduces Development Risk in Rare Oncology Indication

Combining Bayesian Decision-Making with Frequentist Final Analysis in Phase 3 Oncology Trial

Optimizing Biosimilar Development with an Adaptive Design Approach

Download Oncology Designs eBook